Print

Print


Manganese May Speed Up Parkinson's Symptoms

Study finds overexposure to element may spell trouble for those at risk
By Serena Gordon HealthScout Reporter MONDAY, Dec. 18
(HealthScout) --
Manganese is an essential element we all need to survive.  However, too
much of it can be toxic and may speed up the development of Parkinson's
disease, new research shows.

A study, published in this month's issue of Neurotoxicology and
Teratology, found that while manganese exposure does not cause
Parkinson's, higher than normal levels of it may cause symptoms of the
disease to show up much earlier in susceptible patients.

Recent proposals to add manganese to gasoline prompted the
researchers to tackle the topic, says study author Donald Smith, an
associate professor of environmental toxicology at the University of
California in Santa Cruz.

Such a move would increase the levels of manganese exposure in the
environment, Smith says, adding "it's important to pay attention to how
environment plays a role in diseases like Parkinson's."

Parkinson's is a chronic neurological disease that can cause tremors on
one side of the body, slowness of movement, stiffness in the limbs and
gait and balance problems.

For this study, Smith and his colleagues examined four groups of rats.
One group had a condition similar to what humans who have not yet
developed symptoms of Parkinson's have. Another group was exposed
to higher levels of manganese, and a third group had both the pre-
Parkinson condition and the manganese exposure. The final group had
neither.

The rats were exposed to levels of manganese that are higher than what
is currently found in the environment. But the exposure was less than
what those who work with manganese -- welders, miners and others --
get on a daily basis, says Smith.

The rat group with pre-Parkinson's that was exposed to manganese did
significantly worse on several tests than any of the other groups, says
Smith.  This, he says, "suggests an interaction between the two, and
that there is a significantly greater risk of acquiring impairments if
those with pre-Parkinson's are also exposed to high levels of
manganese."

Interestingly, Parkinson's and an overexposure to manganese seem to
affect different parts of the brain, says Smith, and this creates an
additive effect, making the damage to one area worse than it otherwise
might be.

Dr. Sandra Shuman, an associate professor of neurology at the Temple
University School of Medicine in Philadelphia, says the study is
interesting but she has some questions about the findings.  For example,
the Parkinson-like condition was induced in the rats, and Shuman
believes the way it was induced might have caused some symptoms on
its own.

But, she says, the study seems to suggest there are those who "might
never develop Parkinson's if they are not exposed to the toxicity of
manganese."

The idea that it might be added to gasoline is worrisome, she adds,
because it would mean much more airborne manganese exposure. There
is already existing data showing that miners in South America develop
Parkinson-like symptoms very early in life, she adds.

What To Do

Smith says current environmental levels of manganese are not a
problem. But, he says, if the oil companies decide to use manganese as a
gasoline additive, then there may be cause for concern. And he
recommends that anyone working with manganese follow federal safety
guidelines for working with the element.